Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward O'Connor

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Antimicrobial Agents and Chemotherapy|July 20, 2016
Efficacy Projection of Obiltoxaximab for Treatment of Inhalational Anthrax across a Range of Disease SeverityBrent J Yamamoto, Annette M Shadiack, Sarah Carpenter, et al.
Poultry Science|May 8, 2026
Hormetic dose-response of pure hydroxytyrosol in laying hens: Optimal dose for egg shelf-life extension and yolk docosahexaenoic (DHA) and eicosapentaenoic (EPA) acid concentrationMarcel Manente Boiago, Nauan Lima da Silva, Andressa Vilani, et al.
Cell|June 19, 2018
A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate CancerDavid Y Takeda, Sándor Spisák, Ji-Heui Seo, et al.
JCI Insight|May 23, 2022
Response to supraphysiological testosterone is predicted by a distinct androgen receptor cistromeXintao Qiu, Lisha G Brown, Jennifer L Conner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2019
A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2)Ying Z Mazzu, Joshua Armenia, Goutam Chakraborty, et al.
Nature Communications|May 13, 2022
MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targetsXintao Qiu, Nadia Boufaied, Tarek Hallal, et al.
Nature Communications|January 21, 2023
Epigenomic charting and functional annotation of risk loci in renal cell carcinomaAmin H Nassar, Sarah Abou Alaiwi, Sylvan C Baca, et al.
Nature Communications|March 31, 2021
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancerSylvan C Baca, David Y Takeda, Ji-Heui Seo, et al.
Nature Medicine|October 9, 2019
Genome-wide germline correlates of the epigenetic landscape of prostate cancerKathleen E Houlahan, Yu-Jia Shiah, Alexander Gusev, et al.
Bioanalysis|March 25, 2017
The 10th GCC Closed Forum: rejected data, GCP in bioanalysis, extract stability, BAV, processed batch acceptance, matrix stability, critical reagents, ELN and data integrity and counteracting fraudStephanie Cape, Rafiq Islam, Corey Nehls, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|July 20, 2016
Efficacy Projection of Obiltoxaximab for Treatment of Inhalational Anthrax across a Range of Disease SeverityBrent J Yamamoto, Annette M Shadiack, Sarah Carpenter, et al.
Poultry Science|May 8, 2026
Hormetic dose-response of pure hydroxytyrosol in laying hens: Optimal dose for egg shelf-life extension and yolk docosahexaenoic (DHA) and eicosapentaenoic (EPA) acid concentrationMarcel Manente Boiago, Nauan Lima da Silva, Andressa Vilani, et al.
Cell|June 19, 2018
A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate CancerDavid Y Takeda, Sándor Spisák, Ji-Heui Seo, et al.
JCI Insight|May 23, 2022
Response to supraphysiological testosterone is predicted by a distinct androgen receptor cistromeXintao Qiu, Lisha G Brown, Jennifer L Conner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2019
A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2)Ying Z Mazzu, Joshua Armenia, Goutam Chakraborty, et al.
Nature Communications|May 13, 2022
MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targetsXintao Qiu, Nadia Boufaied, Tarek Hallal, et al.
Nature Communications|January 21, 2023
Epigenomic charting and functional annotation of risk loci in renal cell carcinomaAmin H Nassar, Sarah Abou Alaiwi, Sylvan C Baca, et al.
Nature Communications|March 31, 2021
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancerSylvan C Baca, David Y Takeda, Ji-Heui Seo, et al.
Nature Medicine|October 9, 2019
Genome-wide germline correlates of the epigenetic landscape of prostate cancerKathleen E Houlahan, Yu-Jia Shiah, Alexander Gusev, et al.
Bioanalysis|March 25, 2017
The 10th GCC Closed Forum: rejected data, GCP in bioanalysis, extract stability, BAV, processed batch acceptance, matrix stability, critical reagents, ELN and data integrity and counteracting fraudStephanie Cape, Rafiq Islam, Corey Nehls, et al.
Pageof 3